Teck Resources LimitedPartnershipTeck Resources signed a Strategic Investment Agreement with Canada…RivianCapital RaisingRivian announced a 75 million share public offering, indicating…ConcentrixRestructuringConcentrix issued a material revenue guidance downgrade for 2026,…Caravel Autism HealthGeographic ExpansionCaravel Autism Health is opening a new state-of-the-art autism…ResMedMa ActivityResMed to sell MatrixCare business to Frazier Healthcare Partners…DroneShieldProduct LaunchDroneShield shares rebounding as counter-drone demand builds through 2026,…IpsosLeadership ChangeIpsos appoints Claire Charbit to Head of CEO's Office…Duck Creek TechnologiesMa ActivityDuck Creek Technologies acquired Send, combining Duck Creek's intelligent…SompoMa ActivitySompo acquiring Service Insurance Companies, a monoline workers' compensation…WhatfixPartnershipWhatfix partnered with PTC to provide AI-native digital adoption…WixPartnershipWix partnered with Elavon (U.S. Bank-owned payment processor) to…Pocket FMLeadership ChangePocket FM appointed Abhilash Padival, ex-Bank of America director…DXCGeographic ExpansionDXC opened a flagship 200,000-square-foot AI-first Customer Experience Center…upGradMa ActivityupGrad completed CCI-approved acquisition of Unacademy for ₹2,055 Cr…
MitchelLake Group — Talent for Innovation
Est. 2001·3,000+ placements · six offices · four regions

Company signals · Biotech & Pharma

Sana Biotechnology, Inc.

1 signal in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: Against a Talent Market Index of 111.1 (Hot) (up 5.2 month-on-month), Americas is at rising (+6.3pts) on signal share.

Sana Biotechnology, Inc.: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 24 tracked companies.

Signals at Sana Biotechnology, Inc.

Capital Raising

Americas

Schedule 13G filing indicates potential significant ownership change or investment activity

Leadership read: Fresh capital usually broadens biotech & pharma leadership bench strength — scale, go-to-market and operational depth — rather than any single appointment.

curated · 2026-05-22 · context →

More signals across Biotech & Pharma

Capital Raising · Americas

BridgeBio →

BridgeBio secured funding to support drug launch; United Airlines made an investment into the cell therapy space

Ma Activity · Americas

Biogen →

Biogen announced and closed acquisition of Apellis Pharmaceuticals (immunology and rare diseases) in May 2026, and has just announced a second acquisition of an undisclosed company for $1 billion.

Partnership · Americas

Basecamp Research →

Basecamp Research integrated its EDEN antibiotic and vaccine design models into Claude Science, enabling scientists to design antibiotics and prioritize vaccine targets through Claude's interface.

Product Launch · Americas

Bota Biosciences →

Bota Biosciences released Biology Protocol Language (BPL) and BPL-COGEN, a compiler-verified protocol language and generation pipeline for AI-driven biomanufacturing, announced on bioRxiv.

Product Launch · Americas

Neurocrine Biosciences →

Neurocrine presented CRENESSITY clinical data at ENDO 2026 demonstrating hormone normalization in classic CAH and two-year cardiometabolic and bone health outcomes in adults.

Product Launch · Americas

Boehringer Ingelheim →

Phase 3 trial data for obesity drug survodutide shows 19% discontinuation rate due to side effects, indicating potential safety/tolerability issues that may impact market launch strategy

Weekly briefing

Track companies like Sana Biotechnology, Inc. — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

Invitae — Head of Talent (2018)DNAnexus — Multiple roles (Engineering and Non-Engineering) (2016)

Share: WhatsApp · X · Email